Additionally, we analyzed whole genome sequence data of the CD133+ subpopulation and matching germline DNA and concluded that the tumor studied did not contain any clinically actionable mutations (Tables S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11, S12 in Information S2 and Figure S8 in Information S1). The gene discussed is PROM1; the disease is neoplasm.